SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Papa, N D.
Right arrow Articles by Meroni, P L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papa, N D.
Right arrow Articles by Meroni, P L
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-infiammatory phenotype in vitro

N Del Papa

E Raschi

Department of Internal Medicine; Division of Nephrology and Dialysis-IRCCS Policlinico, University of Milan and Servizio di Immunologia Clinica, Spedali Civili, Brescia, Italy

G Moroni

Division of Nephrology and Dialysis-IRCCS Policlinico, University of Milan and Servizio di Immunologia Clinica, Spedali Civili, Brescia, Italy

P Panzeri

M O Borghi

Department of Internal Medicine; Division of Nephrology and Dialysis-IRCCS Policlinico, University of Milan and Servizio di Immunologia Clinica, Spedali Civili, Brescia, Italy

C Ponticelli

Division of Nephrology and Dialysis-IRCCS Policlinico, University of Milan and Servizio di Immunologia Clinica, Spedali Civili, Brescia, Italy

A Tincani

G Balestrieri

Servizio di Immunologia Clinica, Spedali Civili, Brescia, Italy

P L Meroni

Department of Internal Medicine; Division of Nephrology and Dialysis-IRCCS Policlinico, University of Milan and Servizio di Immunologia Clinica, Spedali Civili, Brescia, Italy

Affinity purified immunoglobulin G (IgG) fractions from systemic lupus erythematosus (SLE) patients positive for anti-endothelial cell antibodies (AECA) bind human umbilical vein endothelial cell (HUVEC) monolayers. In vitro incubation of serial protein concentrations of SLE AECA IgG induces a dose-dependent endothelial activation: i) increase of functional adhesion of the monocytic cell line U937; ii) upregulation of E-Selectin, ICAM-1, VCAM-1 expression evaluated by a cell solid-phase enzyme linked immunoassay; and iii) increased secretion of interleukin (IL)-6 in the culture supernatants. Control experiments carried out with HUVEC monolayers incubated with IgG fractions from normal healthy controls or from AECA negative SLE sera do not affect at all endothelial adhesion molecule expression or pro-inflammatory cytokine secretion. The AECA IgG effects are not related to both anti-phospholipid or anti-DNA activities.

Taken together the findings suggest that these autoantibodies might be important in recruiting and in activating mononuclear leukocytes responsible for vessel wall infiltration and raise the possibility that AECA might display a pathogenic role in SLE vessel damage.

Key Words: systemic lupus erythematosus • anti-endothelial cell antibodies • adhesion molecules • cytokines

Lupus, Vol. 8, No. 6, 423-429 (1999)
DOI: 10.1177/096120339900800603


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
D. Domiciano, J. Carvalho, and Y. Shoenfeld
Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases
Lupus, November 1, 2009; 18(13): 1233 - 1238.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
F. Montecucco and F. Mach
Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis
Rheumatology, January 1, 2009; 48(1): 11 - 22.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. Jiang, J.-j. Zhang, J.-c. Lv, G. Liu, W.-z. Zou, M.-h. Zhao, and H. Zhang
Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3921 - 3927.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. L. Gautier, T. Huby, B. Ouzilleau, C. Doucet, F. Saint-Charles, G. Gremy, M. J. Chapman, and P. Lesnik
Enhanced Immune System Activation and Arterial Inflammation Accelerates Atherosclerosis in Lupus-Prone Mice
Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1625 - 1631.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. J. Florey, M. Johns, O. O. Esho, J. C. Mason, and D. O. Haskard
Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between Fc{gamma}RIIa and CXCR1/2
Blood, May 1, 2007; 109(9): 3881 - 3889.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Belizna, A Duijvestijn, M Hamidou, and J W Cohen Tervaert
Antiendothelial cell antibodies in vasculitis and connective tissue disease
Ann Rheum Dis, December 1, 2006; 65(12): 1545 - 1550.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
G R V Hughes and H Phillips
Mycophenolate mofetil and cardiovascular disease
Lupus, November 1, 2006; 15(11_suppl): 1 - 2.
[Abstract] [PDF]


Home page
LupusHome page
S I van Leuven, J J. Kastelein, D P D'Cruz, G R Hughes, and E S Stroes
Atherogenesis in rheumatology
Lupus, March 1, 2006; 15(3): 117 - 121.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
F. C. Hall and N. Dalbeth
Disease modification and cardiovascular risk reduction: two sides of the same coin?
Rheumatology, December 1, 2005; 44(12): 1473 - 1482.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
J. M. Williams, R. Colman, C. J. Brookes, C. O. Savage, and L. Harper
Anti-endothelial cell antibodies from lupus patients bind to apoptotic endothelial cells promoting macrophage phagocytosis but do not induce apoptosis
Rheumatology, July 1, 2005; 44(7): 879 - 884.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-F. Lin, S.-C. Chiu, Y.-L. Hsiao, S.-W. Wan, H.-Y. Lei, A.-L. Shiau, H.-S. Liu, T.-M. Yeh, S.-H. Chen, C.-C. Liu, et al.
Expression of Cytokine, Chemokine, and Adhesion Molecules during Endothelial Cell Activation Induced by Antibodies against Dengue Virus Nonstructural Protein 1
J. Immunol., January 1, 2005; 174(1): 395 - 403.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Rajagopalan, E. C. Somers, R. D. Brook, C. Kehrer, D. Pfenninger, E. Lewis, A. Chakrabarti, B. C. Richardson, E. Shelden, W. J. McCune, et al.
Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity
Blood, May 15, 2004; 103(10): 3677 - 3683.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
N J Abbott, L L. Mendonca, and D E. Dolman
The blood-brain barrier in systemic lupus erythematosus
Lupus, December 1, 2003; 12(12): 908 - 915.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
J E Salmon, G Girardi, and V M Holers
Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis
Ann Rheum Dis, November 1, 2002; 61(90002): ii46 - 50.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. S. Segal, A. Bihorac, and M. Koc
Circulating endothelial cells: tea leaves for renal disease
Am J Physiol Renal Physiol, July 1, 2002; 283(1): F11 - F19.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
V. M. Holers, G. Girardi, L. Mo, J. M. Guthridge, H. Molina, S. S. Pierangeli, R. Espinola, L. E. Xiaowei, D. Mao, C. G. Vialpando, et al.
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
J. Exp. Med., January 22, 2002; 195(2): 211 - 220.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A S Wierzbicki
Lipid-lowering drugs in lupus: an unexplored therapeutic intervention
Lupus, March 1, 2001; 10(3): 233 - 236.
[Abstract] [PDF]



Advertisement